Ptc Therapeutics (PTCT) Cash from Operations (2012 - 2026)

Ptc Therapeutics' Cash from Operations history runs 15 years deep, the most recent figure standing at 59042000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 106.79% year-over-year to 59042000.0; the TTM figure through Mar 2026 stood at 217949000.0 (down 131.51% YoY), while the FY2025 annual figure was 711196000.0, up 760.42% from the prior year.
• Cash from Operations was 59042000.0 for Q1 2026 at Ptc Therapeutics, down from 34273000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 870103000.0 in Q1 2025 to a low of 165963000.0 in Q4 2022.
• Historically, Cash from Operations has averaged 1729058.82 across 5 years, with a median of 55242000.0 in 2022.
• The sharpest annual moves came in 2024 and 2025: Cash from Operations tumbled 430.28% in 2024, then soared 1129.64% in 2025.
• A 5-year view of Cash from Operations shows it stood at 165963000.0 in 2022, then soared by 39.57% to 100288000.0 in 2023, then surged by 70.08% to 30004000.0 in 2024, then slipped by 14.23% to 34273000.0 in 2025, then tumbled by 72.27% to 59042000.0 in 2026.
• The last three Cash from Operations figures came in at 59042000.0 (Q1 2026), 34273000.0 (Q4 2025), and 66301000.0 (Q3 2025), per Business Quant data.